Condition
Transplantation, Lung
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05125406Not ApplicableCompletedPrimary
Prevention of ICU-Related Anxiety in Lung Transplantation by Virtual Reality Therapy - PIRAT Study
NCT04198506Not ApplicableCompletedPrimary
Viral Load Guided Immunosuppression After Lung Transplantation
NCT04643665Completed
Prediction of Pulmonary Graft Dysfunction After Double-lung Transplantation (PGD3-AI Study)
NCT02278952CompletedPrimary
Tacrolimus Adjustment by NFAT-related Gene Expression in Lung Allograft Recipients.
Showing all 4 trials